Merck Sharp & Dohme Sweden AB

Company

Investment-firm

Last deal

$586K

Amount

Post-IPO Equity

Stage

25.11.2018

Date

2

all rounds

$5.59M

Total amount

Financing round

General

About Company
Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1891

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Founded in 1891 and headquartered in Kenilworth, NJ, Merck is a leading research-intensive biopharmaceutical company. Their portfolio includes vaccines, medications, and consumer and animal health products that have the potential to benefit millions of people worldwide. With a mission to discover and develop innovative solutions for various diseases, Merck aims to be at the forefront of the biopharmaceutical industry.
Contacts

Phone number

Social url

Sub-Organizations
10
Sirna Therapeutics

Sirna Therapeutics

Sirna Therapeutics is a biotechnology company that develops RNA interference (RNAi) based treatments for various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Francisco, CA, USA

total rounds

3

total raised

$86.88M
Merck Sharp & Dohme

Merck Sharp & Dohme

MSD has been developing drugs for global health improvement for over a century.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Biotechnology, Manufacturing

Location

City of Belgrade, Serbia
Rosetta Inpharmatics

Rosetta Inpharmatics

Rosetta Inpharmatics LLC is an informational genomics company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Kirkland, WA, USA
Similar Companies
999
MSD

MSD

MSD is a research-based biopharmaceutical company that develops medicines and vaccines for challenging diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Carmanhall and Leopardstown, Dublin, Ireland
MSD

MSD

Merck is a leading global biopharmaceutical company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Health Care, Biotechnology

Location

Kenilworth, NJ, USA
Sanofi

Sanofi

Sanofi is a global biopharmaceutical company that develops and produces drugs and vaccines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biopharma, Biotechnology

Location

Warsaw, Poland
Cephalon

Cephalon

Teva Pharmaceuticals is a global pharmaceutical company that develops and sells affordable generic drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Health Care

Location

Malvern, PA 19355, USA

count Of Investments

6

Financials

Funding Rounds
2
2

Number of Funding Rounds

$5.59M

Money Raised

Their latest funding was raised on 25.11.2018. Their latest investor Private Capital Advisors. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Private Capital Advisors

Private Capital Advisors

Private Capital Advisors Inc. is a registered investment advisor.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

count Of Investments

1
Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance, helps vaccinate children against deadly diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Non-Profit

Location

Geneva, Switzerland

total rounds

1

total raised

$1B

count Of Investments

1
Investments
21
Date 
name 
Lead 
type 
Raised 
27.05.2024
Yes
$190K
27.03.2023
No
$3.3M
30.03.2022
No
$40M
Friends of Puerto Rico

Friends of Puerto Rico

Friends of Puerto Rico is a non-partisan, non-profit social impact organization.

total rounds

1

total raised

$190K
Mamotest

Mamotest

Mamotest democratizes breast cancer diagnosis and patient guidance using AI.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Health Diagnostics

Location

Mexico City, CDMX, Mexico

total rounds

2

total raised

$4.9M
Qure AI

Qure AI

Qure AI uses artificial intelligence assistance for medical imaging diagnostics, making healthcare more accessible and affordable.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Medical Device

Location

Mumbai, Maharashtra, India

total rounds

4

total raised

$60.33M
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Post-IPO Equity
Yes
Venture - Series Unknown
Private Capital Advisors

Private Capital Advisors

Private Capital Advisors Inc. is a registered investment advisor.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

count Of Investments

1
Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance, helps vaccinate children against deadly diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Non-Profit

Location

Geneva, Switzerland

total rounds

1

total raised

$1B

count Of Investments

1
Acquisitions
35
Eyebiotech acquired by Merck Sharp & Dohme Sweden AB

Eyebiotech acquired by Merck Sharp & Dohme Sweden AB

acquirer

Merck Sharp & Dohme Sweden AB
Merck Sharp & Dohme Sweden AB

date

29.05.2024

type

Acquisition

price

$1.3B
Eyebiotech

Eyebiotech

Eyebiotech develops new therapies for eye diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

3

total raised

$130M
Abceutics acquired by Merck Sharp & Dohme Sweden AB

Abceutics acquired by Merck Sharp & Dohme Sweden AB

acquirer

Merck Sharp & Dohme Sweden AB
Merck Sharp & Dohme Sweden AB

date

05.04.2024

type

Acquisition

price

$208M
Abceutics

Abceutics

Abceutics operates as a biopharmaceutical company.

Prometheus Biosciences acquired by Merck Sharp & Dohme Sweden AB

Prometheus Biosciences acquired by Merck Sharp & Dohme Sweden AB

acquirer

Merck Sharp & Dohme Sweden AB
Merck Sharp & Dohme Sweden AB

date

16.04.2023

type

Acquisition

price

$10.8B
Prometheus Biosciences

Prometheus Biosciences

Prometheus Biosciences develops precision therapeutics and diagnostics for IBD.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Diego, CA, USA

total rounds

6

total raised

$951.84M
Exits
4
Just - Evotec Biologics

Just - Evotec Biologics

Just - Evotec Biologics uses AI/ML and molecular design to accelerate biotherapeutic development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seattle, WA, USA

total rounds

2

total raised

$29M
Seagen

Seagen

Seagen is a biotechnology company developing and commercializing monoclonal antibody-based therapies for cancer and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Bothell, WA, USA

total rounds

7

total raised

$2.22B

count Of Investments

3
Themis Bioscience

Themis Bioscience

Themis Bioscience is a Vienna-based biotech developing vaccines for infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Vienna, Austria

total rounds

11

total raised

$150.22M

People

Founders
1
George W. Merck
George W. Merck

George W. Merck

George W. Merck was born in New York City to George and Friedrike (Schenck) Merck. His father had emigrated from Germany in 1891 to oversee the new office of E. Merck and Company at 62 Wall Street. He was raised in Llewellyn Park, New Jersey where he had access to Thomas Edison's workshop. He graduated from Harvard College with a B.S. in chemistry in 1915. While there, he edited the Harvard Lampoon.

current job

MSD
MSD

organization founded

3

George W. Merck

Employee Profiles
10688

Steven Silverman

Associate principal scientist, process research and development, catalysis

Adam Weiner

Technical operations engineer

Tara Jarousse

Associate director, u.s oncology marketing, keytruda

Rob Schwalje

It executive director: global clinical development, global medical affairs, quality assurance and core

Sagarika Bose

Global cmc and clinical

Lynn Gionta

Associate director, consumer marketing-oncology

Zubia Naji

Senior specialist in global project and alliance management

Kristen Frank

Associate director, human resources bp

Activity

Recent News
10
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month